Xenon Pharmaceuticals Inc.
A biopharmaceutical company focused on developing innovative drugs for neurological disorders. In addition to epilepsy, the company is developing drugs for major depressive disorder and other neurological disorders. The company also works in partnership with other companies on development.
Overview
Overview | |
|---|---|
Country | Canada |
State | |
Employees | 259 |
Founded | 1996 |
Financials | |
|---|---|
Market Capitalization | 3.24B |
Revenue | |
Operating Income | -224.04M |
Operating Margin | |
Net Income | -188.60M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 5112 / 5373 |
Sector : Healthcare | 1045 / 1144 |
Industry : Biotechnology | 574 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 1563 / 5565 |
Sector : Healthcare | 177 / 1182 |
Industry : Biotechnology | 51 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 5066 / 5436 |
Sector : Healthcare | 1036 / 1164 |
Industry : Biotechnology | 573 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3395 / 5330 |
Sector : Healthcare | 415 / 1174 |
Industry : Biotechnology | 111 / 667 |